NCT06910384View on ClinicalTrials.gov

A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

PHASE2RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

August 30, 2027

Study Completion Date

January 30, 2028

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

STR04

autologous bone-marrow-derived mesenchymal stem cells

Trial Locations (1)

78759

RECRUITING

National Neuromuscular Research Institute, Austin

Sponsors
All Listed Sponsors
lead

New England Cell Therapeutics, Inc.

INDUSTRY

NCT06910384 - A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter